UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies

Blood cancer journal (New York), 2015-04, Vol.5 (4), p.e306-e306

2015

Volltextzugriff (PDF)

Coordinated expression of DNAM-1 and LFA-1 in educated NK cells

The Journal of immunology (1950), 2015-05, Vol.194 (9), p.4518-4527

2015

Volltextzugriff (PDF)

DIRECT PARENCHYMAL DELIVERY TO ANY ORGAN OR TUMOR VIA NEXT GENERATION ENDOVASCULAR TECHNIQUE – MINIMALLY INVASIVE AND EFFICIENT METHOD FOR TARGETED CELL AND GENE THERAPY

CYTOTHERAPY, 2024-06, Vol.26 (6), p.S206-S206

2024

Volltextzugriff (PDF)

The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies

Blood cancer journal (New York), 2015-07, Vol.5 (7), p.e321-e321

2015

Volltextzugriff (PDF)

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells

Frontiers in immunology, 2019-10, Vol.10, p.2357-2357

2019

Volltextzugriff (PDF)

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34 blasts in myelodysplastic syndrome

Leukemia, 2010-09, Vol.24 (9), p.1607-1616

2010

Volltextzugriff (PDF)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer

Frontiers in immunology, 2019, Vol.10, p.1047-1047

2019

Volltextzugriff (PDF)

Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow

Leukemia, 2024-03, Vol.38 (3), p.579-589

2024

Volltextzugriff (PDF)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy

Frontiers in immunology, 2021-01, Vol.11, p.621225-621225

2021

Volltextzugriff (PDF)

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Clinical cancer research, 2018-04, Vol.24 (8), p.1834-1844

2018

Volltextzugriff (PDF)

Natural killer cell-mediated immunosurveillance of human cancer

Seminars in immunology, 2017-06, Vol.31, p.20-29

2017

Volltextzugriff (PDF)

54 ADOPTIVELY TRANSFERRED HAPLOIDENTICAL NK CELLS AGAINST REFRACTORY MDS, HIGH-RISK MDS AND REFRACTORY AML AS A BRIDGE TO TRANSPLANTATION. COMPLETE REMISSION ASSOCIATED WITH DETECTABLE NK CELLS

Leukemia research, 2015-04, Vol.39, p.S25-S26

2015

Volltextzugriff (PDF)

Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X

Frontiers in immunology, 2019-06, Vol.10, p.1262-1262

2019

Volltextzugriff (PDF)

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

The Journal of immunology (1950), 2009-10, Vol.183 (8), p.4921-4930

2009

Volltextzugriff (PDF)

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Haematologica (Roma), 2014-06, Vol.99 (6), p.e81-e83

2014

Volltextzugriff (PDF)

The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome

BMC cancer, 2021-05, Vol.21 (1), p.500-500, Article 500

2021

Volltextzugriff (PDF)

Comprehensive Exploration of NK Cell Education in ADCC Triggered By a Monoclonal Antibody or a Bispecific Killer Engager Molecule (BiKE)

BLOOD, 2022-11, Vol.140 (Supplement 1), p.8350-8350

2022

Volltextzugriff (PDF)

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up

PloS one, 2018-08, Vol.13 (8), p.e0202651-e0202651

2018

Volltextzugriff (PDF)

KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity

The Journal of immunology (1950), 2024-03, Vol.212 (5), p.868-880

2024

Volltextzugriff (PDF)

Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer

Signal transduction and targeted therapy, 2023-08, Vol.8 (1), p.316-316, Article 316

2023

Volltextzugriff (PDF)

Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells

Leukemia, 2023, Vol.37 (9), p.1830-1841

2023

Volltextzugriff (PDF)

Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5

Oncoimmunology, 2019-01, Vol.8 (2), p.e1534664-e1534664

2019

Volltextzugriff (PDF)

CRISPR/Cas9-Based Gene Engineering of Human Natural Killer Cells: Protocols for Knockout and Readouts to Evaluate Their Efficacy

Methods in molecular biology (Clifton, N.J.), 2020, Vol.2121, p.213

2020

Volltextzugriff (PDF)

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Blood advances, 2022-06, Vol.6 (11), p.3352-3366

2022

Volltextzugriff (PDF)

Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness

Frontiers in immunology, 2019, Vol.10, p.2164-2164

2019

Volltextzugriff (PDF)

1 – 25 von 567

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(390)
Mit Volltextzugriff
(527)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies

Coordinated expression of DNAM-1 and LFA-1 in educated NK cells

DIRECT PARENCHYMAL DELIVERY TO ANY ORGAN OR TUMOR VIA NEXT GENERATION ENDOVASCULAR TECHNIQUE – MINIMALLY INVASIVE AND EFFICIENT METHOD FOR TARGETED CELL AND GENE THERAPY

The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34 blasts in myelodysplastic syndrome

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer

Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Natural killer cell-mediated immunosurveillance of human cancer

54 ADOPTIVELY TRANSFERRED HAPLOIDENTICAL NK CELLS AGAINST REFRACTORY MDS, HIGH-RISK MDS AND REFRACTORY AML AS A BRIDGE TO TRANSPLANTATION. COMPLETE REMISSION ASSOCIATED WITH DETECTABLE NK CELLS

Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome

Comprehensive Exploration of NK Cell Education in ADCC Triggered By a Monoclonal Antibody or a Bispecific Killer Engager Molecule (BiKE)

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up

KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity

Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer

Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells

Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5

CRISPR/Cas9-Based Gene Engineering of Human Natural Killer Cells: Protocols for Knockout and Readouts to Evaluate Their Efficacy

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness

Suchergebnisse filtern